Inactive Instrument

Other languages SofWave Medical Ltd. TEL AVIV STOCK EXCHANGE

Equities

SofWave Medical Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-06
SofWave Medical Ltd. Appoints James Bartholomeusz as Chief Innovation Officer	02-12
Sofwave Medical Receives 510(K) Marketing Clearance for Pure Impact Strength and Muscle Toning Body Module Utilizing Plyopulse EMS Technology	01-03
SofWave Medical Ltd. Receives FDA Clearance of Superb?? Technology for Improvement of the Appearance of Skin Laxity on the Upper Arm	12-26
SofWave Medical Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-08
Sofwave Medical Announces FDA Clearance of SUPERB? Technology For Treatment of Acne Scars	30/08/23
SofWave Medical Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	08/08/23
Sofwave Medical Ltd. Gains Additional U.S. Patent Protection for the Company's Proprietary SUPERBâ„¢ Technology	05/07/23
SofWave Medical Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	08/03/23

No results for this search